Get the Stockscreener App
5.55
0.00%
0.00
Journey Medical Corp stock is traded at $5.55, with a volume of 107.50K.
It is up +0.00% in the last 24 hours and down -3.65% over the past month.
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
See More
Previous Close:
$5.55
Open:
$5.55
24h Volume:
107.50K
Relative Volume:
1.18
Market Cap:
$115.94M
Revenue:
$79.89M
Net Income/Loss:
$-12.35M
P/E Ratio:
-2.5227
EPS:
-2.2
Net Cash Flow:
$32.92M
1W Performance:
+6.12%
1M Performance:
-3.65%
6M Performance:
+54.17%
1Y Performance:
+11.22%
1-Day Range:
$5.30
$5.69
1-Week Range:
$5.05
$5.88
52-Week Range:
$2.85
$8.11
Journey Medical Corp Stock (DERM) Company Profile
Name
Journey Medical Corp
Sector
Phone
480-434-6670
Address
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
5.55 | 115.94M | 79.89M | -12.35M | 32.92M | -2.20 |
|
ZTS
Zoetis Inc
|
176.74 | 80.59B | 9.15B | 2.43B | 2.31B | 4.92 |
|
HLN
Haleon Plc Adr
|
9.72 | 44.17B | 14.26B | 1.55B | 0 | 0.3327 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 42.61B | 30.27B | 1.93B | 3.45B | 0.444 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.77B | 16.77B | -959.00M | 1.37B | -2.00 |
|
VTRS
Viatris Inc
|
13.22 | 15.73B | 15.05B | -883.30M | 1.89B | 1.53 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-22-24 | Initiated | Rodman & Renshaw | Buy |
| Jun-28-24 | Resumed | ROTH MKM | Buy |
| Dec-07-21 | Initiated | B. Riley Securities | Buy |
Journey Medical Corp Stock (DERM) Latest News
Women of Influence: Erica Conroy's journey from the lab to the C-SuiteColumbus Business First - The Business Journals
FY2024 EPS Estimate for Journey Medical Decreased by Analyst - MarketBeat
FY2024 EPS Estimates for Journey Medical Boosted by B. Riley - MarketBeat
Showcasing the Journey of Researchers and Entrepreneurs at UP Manila’s Salinlohiya 2024 - University of the Philippines Manila
NY AI medical company wins global health tech competition at Scientific Sessions 2024 - American Heart Association
Journey Medical Co. (NASDAQ:DERM) Short Interest Down 20.7% in October - MarketBeat
Despite Journey Medical's Pullback, Insiders Still Gained US$118k - Yahoo Finance
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - Yahoo Finance
Topgolf Callaway Q3 Earnings & Revenues Top Estimates, Fall Y/Y - Yahoo Finance
Journey Medical Corp (DERM) Q3 2024 Earnings: Revenue Hits $14.6M, EPS Loss of $0.12 Beats Estimates - GuruFocus.com
Journey Medical earnings beat by $0.05, revenue topped estimates - Investing.com
Journey Medical Corporation (DERM) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Runway Growth Finance Corp. (RWAY) Q3 Earnings and Revenues Lag Estimates - Yahoo Finance
Earnings Flash (DERM) JOURNEY MEDICAL CORPORATION Reports Q3 Revenue $14.6M - Marketscreener.com
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - Yahoo Finance
Lost emperor penguin recovering after record journey across Southern Ocean - ABC News
Best travel insurance companies in 2024 - USA TODAY
FY2024 EPS Estimates for Journey Medical Raised by Analyst - MarketBeat
Q3 EPS Estimates for Journey Medical Reduced by Roth Capital - Defense World
FDA approves Journey Medical’s rosacea treatment Emrosi - Yahoo Finance
Journey gets FDA okay for Emrosi, releases preliminary Q3 earnings report (NASDAQ:DERM) - Seeking Alpha
US FDA approves Journey Medical's drug for long-term skin condition - Reuters
Journey Medical gains as US FDA approves skin condition drug - XM
Journey Medical (DERM) Soars 7.3%: Is Further Upside Left in the Stock? - Yahoo Finance
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea - Yahoo Finance
mWell says users gain access to 26 MPH hospitals - BusinessWorld Online
Seven PDUFA dates on FDA’s November calendar - BioCentury
Nahdi continues the growth journey with 9.0% yoy revenue increase and meeting the profitabilty guidance - ZAWYA
Biotech Stocks Facing FDA Decision In November 2024 - RTTNews
Journey Medical Co. (NASDAQ:DERM) Short Interest Update - MarketBeat
Pixee Medical Inc. Announces Josh Hagel Appointed Vice President of Sales, US - OrthoSpineNews
The Nugget Trap (RWA) Token Offering NGTG$$ commences trading - ForexTV.com
Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference - The Manila Times
Sonoma Pharmaceuticals (SNOA) Surges Amid Positive Analyst Ratin - GuruFocus.com
Her billionaire marriage broke up. Her VP campaign fizzled. Now she’s a Trump-world star. - The Washington Post
GE HealthCare announces CareIntellect for Oncology, harnessing AI to give clinicians an easy way to see the patient journey in a single view - Yahoo Finance
Live Webinar | Overcoming SASE Adoption Journey Challenges for USA Inc. - BankInfoSecurity.com
Sam Champion opens up about cancer journey - Good Morning America
SWK Holdings Provides Portfolio Update - AccessWire
Tevogen Bio Thanks Warren Township for Proclamation Honoring CEO Dr. Ryan Saadi, Nobel Peace Prize Nomination, and the Company's Mission to Address Health Inequality - The Manila Times
Will It Be A Smooth Sailing For Journey Medical's Rosacea Drug At The FDA? - RTTNews
Journey Medical Co. (NASDAQ:DERM) Sees Large Increase in Short Interest - MarketBeat
The rather unusual jet at Dunedin Airport and its epic journey here - Stuff
GE HealthCare - linkedin
Microsoft expands AI capabilities to shape a healthier future - Microsoft
Baird Medical Lists in the U.S. on the Nasdaq Exchange - Yahoo Finance
SWK Holdings announces board member resignation - Investing.com
Journey Medical Corp Stock (DERM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.83%
1.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):